Dr Akanksha Agarwal explains how these popular procedures differ, who may consider them, costs in India, risks, and why ...
Slate Medicines has emerged with hopes of cracking the code for delivering an injectable novel drug class to prevent ...
Raleigh-based Slate Medicines just pulled in a hefty $130 million Series A, a war chest the startup says will fuel development of SLTE‑1009, an in‑licensed anti‑PACAP monoclonal antibody aimed at ...
Influencers and celebrities are using unapproved peptide therapies. What does the science say about them?
The biotech is developing a drug aimed at a protein called PACAP, which has emerged as a potentially new way to prevent the onset of migraines.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results